Novavax Inc (NVAX)
$16.39
0.00 (0.00%)
NVAX Stock Quote Delayed 30 Minutes
NVAX Stock: Novavax Climbs on New Vaccine Manufacturing Deal
Novavax continues to excite investors with new plans to expand its manufacturing capacity for its coronavirus vaccine. Here's what to know.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.22B
PE Ratio
-5.12
EPS
-3.2
Volume (Avg. Vol.)
41,176
Day's Range
-
52-Week Range
$3.53 - $23.86
Dividend & Yield
N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
Novavax’s Run to $200 by the End of 2020 Is Looking Less Likely
Novavax signed an agreement with the Canadian government for its potential Covid-19 vaccine Aug. 31. NVAX stock has been falling ever since.
It’s Not Over Yet for Novavax Stock, but Wait for Another Pullback
While factors could change the game, you can't say it's over for NVAX stock. Still, wait for lower prices before diving into high-risk, high-return Novavax.
Confidence Is Essential for Novavax Stock Investors
NVAX stock is a binary trade because they are trying to make sure this time is different. Novavax can be a risky trade, but profitable.
This Is No Time to Lack Conviction on Novavax
NVAX stock is up over 2,000% since March. But as the clinical trials advance, investors need to decide if they're in or out.
When It Comes to Novavax Stock, It’s All About Clinical Results
Novavax had a good run in the last few months and after the August drop, investors will look forward to the clinical study numbers
Novavax’s Cinderella Tale is Heading Toward an Alternative Ending
As one of the viable Covid-19 vaccine producers, Novavax was a Cinderella story of 2020. But a harsh reality check is making NVAX stock look less credible.
This Novavax Stock Pullback May Be a Massive Opportunity
With biotech companies, regardless of what drug, therapy or vaccine being worked on, clinical trials are vital and that's certainly the case with NVX-CoV2373 stepping into the second stage. This trial is relevant because it will include testing on humans in age groups deemed highly susceptible to contracting Covid-19 and dying from the illness.
Novavax Is Conducting Clinical Trials: The Ride In NVAX Stock Will Continue To Be Wild
NVAX stock has been among the hottest stocks in 2020, but it still remains a risky investment
Novavax Is Worth a Bet in the Vaccine Race
NVAX stock appears to be a decent wager in the vaccine sweepstakes despite recent volatility and some insider selling.
Wait for a Pullback Before Investing in Novavax
Having two major vaccine candidates in its repertoire makes NVAX stock an attractive investment, but a pullback is imperative.
3 Key Questions to Ask Before Buying Novavax
Vaccine approval certainly can drive NVAX stock back to new highs after a recent pullback. But risks go beyond vaccine development.
All Bets Are Off With Novavax, So Tread Carefully
With NVAX stock, it's debatable whether vaccine quality will be its advantage. At today's prices, take a wait-and-see approach.
Novavax Is the Ultimate Coronavirus Stock
Novavax has failed at late-stage clinical trials before, but if its COVID-19 vaccine even has 50% efficacy it could open up a huge global opportunity.
This Mega-Scale Deal Just Gave You a Reason to Buy Novavax
In the race to bring a Covid-19 vaccine to market, Novavax just scored a major coup and that's super-bullish for NVAX stock.
4 Top Stock Trades for Thursday: HD, NVAX, RST, PENN
Home Depot, Novavax, Rosetta Stone and Penn National Gaming were our top stock trades for Thursday. That said, let's look at the charts now.
Novavax News: Why NVAX Stock Is Plunging 16% Today
Novavax (NVAX) news for Thursday concerning includes the company's stock falling hard on talk of a vaccine for the novel coronavirus.
Novavax Looks Like a Winner With Its Vaccine Results
Novavax looks like a winner with its positive Covid-19 vaccine results. NVAX stock is worth at least 35% more than today based on widespread acceptance of its vaccine.
